Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application.

Yang, Fei

Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. [electronic resource] - The Journal of international medical research May 2019 - 1817-1828 p. digital

Publication Type: Journal Article; Review

1473-2300

10.1177/0300060519837103 doi


Cardiomyopathies--diagnosis
Cardiotonic Agents--therapeutic use
Cardiotoxicity
Humans
Prognosis
Sepsis--complications
Simendan--therapeutic use